Cabaletta Bio Inc (NASDAQ:CABA) currently has a daily average trading volume of 1.33M but it saw 1141239 shares traded in last market. With a market cap of 94.89M USD, the company’s current market price of $1.87 came rising about 7.47 while comparing to the previous closing price of $1.74. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.50 and as low as $0.99.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Evercore ISI which downgraded the stock as “In-line” in its note to investors issued on December 20, 2024, recommending a price target of between $15 and $6 for it. Wells Fargo downgraded its recommendation for the stock as a “Equal Weight” from “Overweight” on December 19, 2024 while assigning a price target range of $12-$6. UBS issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, CABA’s stock price is moving -0.53% down while it is 42.75% when we observe its performance for the past one month. Year-to-date it is -17.62% down and over the past year, the stock is showing a downside performance of -83.32%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.61 while estimate for next year EPS is -2.35. In next quarter, company is expected to be making quarterly sales of $833.33k as analysts are expecting the sales for current fiscal year at $5.83M and seeing the company making $3.33M in sales next year. Moreover, analysts are in estimates of $4.17M for current-quarter revenue.
Currently, Cabaletta Bio Inc’s total number of outstanding shares is 50.74M with 2.98% of that held by the insiders while 72.40% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -96.65% and return on equity (ROE) at -73.85%. Stock’s beta reads 2.80. Stock has a price to book (P/B) ratio of 0.78. Its return on asset (ROA) is -62.51% on average.
